CARDIAC-SURGERY AND DISTRIBUTION OF THE LEUKOCYTE L1 PROTEIN-CALPROTECTIN

被引:20
作者
SEMB, AG
GABRIELSEN, TO
HALSTENSEN, TS
FAGERHOL, MK
BRANDTZAEG, P
VAAGE, J
机构
[1] Department of Dermatology, Oslo
[2] Laboratory for Immunohistochemistry and Immunopathology (LIIPAT), University of Oslo, Oslo, Rikshospitalet
[3] Department of Immunology and Blood Bank, University of Oslo, Ullevål Hospital, Oslo
[4] Surgery, University of Tromsø
关键词
CARDIOPULMONARY BYPASS; LEUKOCYTES; LEUKOCYTE ACTIVATION; L1; MYOCARDIAL REPERFUSION;
D O I
10.1016/1010-7940(91)90053-M
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Activated polymorphonuclear leukocytes (PMN) secrete lysosomal enzymes, eicosanoids and toxic oxygen metabolites. In cardiac surgery patients, we measured arterial plasma levels of PMN and L1 (calprotectin), a prominent granulocyte protein, during cardiopulmonary bypass (CPB). The myocardial arterio-venous gradients were evaluated during reperfusion after cold cardioplegic arrest (n = 10). The arterial plasma concentration of L1 increased during CPB from 344 +/- 71-mu-g/l (mean +/- SD) preoperatively to 5221 +/- 1267-mu-g/l at the end of CPB (P < 0.001). Simultaneously, the number of circulating PMN also increased (from 4.4 +/- 0.4 x 10(9)/l to 9.1 +/- 1.2 x 10(9)/l (P < 0.05)). There was a positive correlation between the mean number of circulating PMN and the plasma level of L1 at all sampling times during CPB (r = 0.93, P < 0.05). A coronary sequestration of both L1 (P < 0.006) and PMN (P < 0.002) was found after 5 min reperfusion. This was not present at 15 and 30 min reperfusion. The coronary entrapment of L1 and PMN did not covary significantly, and was unrelated to both the time of cardioplegic arrest and the arterial levels of L1 and PMN. In conclusion, the increased plasma concentrations of PMN and L1 during CPB and the coronary sequestration of both PMN and L1 may be factors in the pathogenesis of reperfusion injury of the myocardium.
引用
收藏
页码:363 / 367
页数:5
相关论文
共 28 条
[1]  
Antonsen S., Brandslund I., Clemensen S., S0feldt Madsen T., Alstrup P., Neutrophil lysosomal enzyme release and complement activation during cardiopulmonary bypass, Scand J Thorac Cardiovasc Surg, 21, pp. 47-52, (1987)
[2]  
Berntzen H.B., Munthe E., Fagerhol M.K., The major leukocyte protein LI as an indicator of inflammatory joint disease, Scand J Rheumatol, 76, (1988)
[3]  
Berntzen H.B., Munthe E., Fagerhol M.K., A longitudinal study of the leukocyte protein LI as an indicator of disease activity in patients with rheumatoid arthritis, J Rheumatol, 16, pp. 1416-1420, (1990)
[4]  
Brandtzaeg P., Dale I., Fagerhol M.K., Distribution of a formalin-resistant myelomonocytic antigen (LI) in human tissue 2: Normal and aberrant occurrence in various epithelia, Am J Clin Pathol, 84, pp. 24-34, (1987)
[5]  
Cavarocchi N.C., England M.D., Schaff H.V., Russo P., Orzulak T.A., Schell W.A., O'brien J.F., Pluth J.R., Oxygen free radical generation during cardiopulmonary bypass: Correlation with complement activation, Circulation, 74, pp. 130-133, (1986)
[6]  
Craddock P.R., Granulocyte adherence and margination, The Granulocyte: Function and Clinical Utilization, (1977)
[7]  
Dale I., Brandtzaeg P., Fagerhol M., Scott H., Distribution of a new myelomonocytic antigen (LI) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin, Am J Clin Pathol, 84, pp. 24-34, (1985)
[8]  
Dale I., Fagerhol M., Naesgaard I., Purification and partial characterization of a highly immunogenic human leukocyte protein, the LI antigen, Eur J Biochem, 134, pp. 1-6, (1983)
[9]  
Davies J.M., Sheppard K., Fletcher J., The effects of surgery on the activity of neutrophil granule proteins, Br J Haematol, 53, pp. 5-13, (1983)
[10]  
Fagerhol M., Dale I., Erssen K.B., A radioimmunoassay for a granulocyte protein as a marker in studies on the turnover of such cells, Bull Eur Physiopath Resp, pp. 273-281, (1980)